Skip to main content
Journal cover image

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

Publication ,  Journal Article
Alikhan, A; Sayed, C; Alavi, A; Alhusayen, R; Brassard, A; Burkhart, C; Crowell, K; Eisen, DB; Gottlieb, AB; Hamzavi, I; Hazen, PG; Jaleel, T ...
Published in: J Am Acad Dermatol
July 2019

Hidradenitis suppurativa is a chronic inflammatory disorder affecting hair follicles, with profoundly negative impact on patient quality of life. Evidence informing ideal evaluation and management of patients with hidradenitis suppurativa is still sparse in many areas, but it has grown substantially in the last decade. Part I of this evidence-based guideline is presented to support health care practitioners as they select optimal management strategies, including diagnostic testing, comorbidity screening, and both complementary and procedural treatment options. Recommendations and evidence grading based on the evidence available at the time of the review are provided.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Acad Dermatol

DOI

EISSN

1097-6787

Publication Date

July 2019

Volume

81

Issue

1

Start / End Page

76 / 90

Location

United States

Related Subject Headings

  • United States
  • Severity of Illness Index
  • Risk Assessment
  • Publishing
  • Practice Guidelines as Topic
  • North America
  • Male
  • Immunosuppressive Agents
  • Humans
  • Hidradenitis Suppurativa
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Alikhan, A., Sayed, C., Alavi, A., Alhusayen, R., Brassard, A., Burkhart, C., … Poulin, Y. (2019). North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol, 81(1), 76–90. https://doi.org/10.1016/j.jaad.2019.02.067
Alikhan, Ali, Christopher Sayed, Afsaneh Alavi, Raed Alhusayen, Alain Brassard, Craig Burkhart, Karen Crowell, et al. “North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.J Am Acad Dermatol 81, no. 1 (July 2019): 76–90. https://doi.org/10.1016/j.jaad.2019.02.067.
Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019 Jul;81(1):76–90.
Journal cover image

Published In

J Am Acad Dermatol

DOI

EISSN

1097-6787

Publication Date

July 2019

Volume

81

Issue

1

Start / End Page

76 / 90

Location

United States

Related Subject Headings

  • United States
  • Severity of Illness Index
  • Risk Assessment
  • Publishing
  • Practice Guidelines as Topic
  • North America
  • Male
  • Immunosuppressive Agents
  • Humans
  • Hidradenitis Suppurativa